Get In Touch

The global contraceptives market is estimated to witness considerable growth over the tenure of assessment due to increased prevalence of unwanted pregnancies across the globe. Contraception, also known as birth control, is made to prevent unwanted pregnancies. Methods of contraception might work in several different ways. One such way is prevention of sperm from fertilizing ovum. Such types of prevention could come in the form of contraceptive sponges, cervical caps, diaphragms, and condoms. Holding the ovaries of women from releasing eggs that could be fertilized, which include use of emergency contraceptive pills, vaginal rings, shots, patches, and birth control pills. Then there are intrauterine devices, which are placed into a woman’s uterus and can be kept for a good many years. Sterilization is another method through which a woman can never get pregnant or it could prevent a man from impregnating a sterilized woman.

The choice of birth control is dependent on several deciding factors, which are the desire to have children,  number of sexual partners, frequency to sexual activities, and the health of a person. Based on these factors, a health care practitioner can suggest the best available option.

The global contraceptives market is estimated to rise at a promising rate of growth over the timeframe of analysis due to augmented need for control of population and increased prevalence of sexually transmitted diseases. Implementation of various initiatives that are aimed at bringing down healthcare expenditure related to unwanted pregnancies and rise in the level of awareness about the effects of unwanted pregnancies are estimated to support growth of the global contraceptives market in the years to come.

The global contraceptives market is expected to rise at 6.1% CAGR over the assessment period, 2017 to 2025. It is anticipated that the market value of the global contraceptives market would reach a figure of around US$ 37,242.7 mn by the end of 2025. 

The global contraceptives market is regarded as a fragmented one with the presence of many local as well as international players. Some of the prominent players that are profiled in the global contraceptives market comprise Reckitt Benckiser plc, Janssen Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals SA, HLL Lifecare Limited, and Church & Dwight Co., Inc.

global contraceptives market

Rise in the Incidences of Unwanted Pregnancies to Spur Market Growth

The global contraceptives market is likely to observe growth in the increasing initiatives by governments to raise awareness about adverse effects of population explosion and unwanted pregnancies. Different programs aim to cater to the rising demand for modern contraception methods and provide with sexual and reproductive health services. These health services should comprise participation of young people, adolescents, and women at all phases of evaluation, implementation, and planning. These day many women are delaying their motherhood as career prioritization has taken place amongst many women. More women are increasingly getting aware about the cost of raising a child, increased prevalence about unstable relationships, and worry about job safety. All these factors are likely to propel growth of the global contraceptives market in the years to come.

Some of the major devices of contraception are diaphragms, vaginal implants, intrauterine devices, male and female condoms, sponges, and subdermal implants are some of the main devices and these devices are estimated to account for a large share of the global contraceptives market over the period of assessment. Rise in the awareness level of sexually transmitted disease such as HIV, Gonorrhea, Human Papilloma Virus, Syphilis, and others is expected to drive the demand for contraceptives substantially in the years to come. Benefits of contraceptives are numerous, a case in point is the use of patches, implants, intrauterine devices, and contraceptive pills offer to control menstrual cycle of women. Some of those contraceptives also diminishes the chances of ovarian cysts and uterine cancer, it also assists in the management of endometriosis, makes period less painful and helps in vanishing hormonal acne. Such multiple benefits of contraceptives are likely to bolster growth of the global contraceptives market in the years to come.

Furthermore, rise in the number of gynecologists opting for these devices for the purpose of contraception is estimated to propel growth of the global contraceptives market in the near future. A case in point is Mirena, a hormonal intrauterine device is likely to support growth of the global contraceptives market over the period of analysis.

Contraceptive pills, however, is estimated to dominate the overall contraceptive drugs market due to the presence of a large base of consumers taking them. In addition, various government initiatives and programs to meet the unmet demand of women within the reproductive age bracket are likely to add to the growth of the market in the years to come.

North America to Lead the Market due to Increased Initiatives by Governments

North America is one of the prominent regions in the global contraceptives market and is likely to account for a large chunk of the market over the tenure of assessment. Prevalence of high incidences of abortion together with increased participation of reproductive women in the workforce and very high level of awareness regarding contraceptive products are likely to support growth of the contraceptives market in North America in the years to come. In accordance with the estimates of U.S. Centers for Disease Control and Prevention, in 2011, nearly 45% of all pregnancies were unintended and 75% of all such unintended pregnancies happened to teens in the age group of 15 to 19 years of age. Despite huge amount being spent on the research and development of new technologies the rapid technological progress made, unplanned pregnancy in the US is very high and it has been cause of concern for decades in the region. Government in the US has taken measures to increase the availability of contraceptives through health insurance policies. It has also permitted emergency contraceptives to be  made available as Over The Counter (OTC) drugs.

Global Contraceptives Market: Overview

The report on the contraceptive market analyzes the current and future scenario of the global market. Increase in prevalence of unintended pregnancy, advent of new low cost generics drugs and devices of contraceptives by key players, and increase in adoption and awareness for contraceptives usage in developing countries are the major drivers of the global contraceptive market.

The contraceptive market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global contraceptive market with respect to the segments based on product type, distribution channel and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises porter’s five forces analysis and value chain analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global contraceptive market.

Global Contraceptives Market: Market Segmentation

Based on product type, the contraceptive market is segmented as contraceptives drugs and contraceptive devices. The contraceptive drug is further segmented into oral contraceptive, contraceptive injectable, and topical contraceptive patch. Oral contraceptive is further segmented into combined contraceptives and mini-pills. Contraceptive devices is segmented into male contraceptives and female contraceptives. Female contraceptive is segmented into female condoms, contraceptive diaphragms, contraceptive sponges, contraceptive vaginal rings, intrauterine devices, sub-dermal contraceptive implants, and non-surgical permanent contraception devices. The product market segments have been analyzed based on available drugs and devices, product pipeline for new contraceptives products, cost-effectiveness, and preference for contraceptive product among population. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Based on distribution channel, contraceptives market is segmented into hospitals pharmacy, independent pharmacy, online platform, clinics and others. The market segments have been extensively analyzed based on availability of different contraceptive products, availability of these products at different distribution channels and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

Geographically, the global contraceptive market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Global Contraceptives Market: Competitive Landscape

The report also profiles major players in the global contraceptive market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report includes Merck & Co., Inc., Cipla Inc., Allergan plc, Bayer AG, HLL Lifecare Limited, Mankind Pharma, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Reckitt Benckiser Group plc., and others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

The Global Contraceptives Market is segmented as given below:

by Product

  • Contraceptive Drugs
    • Oral Contraceptives
      • Combined Contraceptives
      • Mini-pills
    • Contraceptive Injectable
    • Topical Contraceptive Patch
  • Contraceptive Devices
    • Male Contraceptive Devices
    • Female Contraceptive Devices
      • Female Condoms
      • Contraceptive Diaphragms
      • Contraceptive Sponges
      • Contraceptive Vaginal Rings
      • Intrauterine Devices
      • Sub-dermal Contraceptives Implants
      • Non-Surgical Permanent Contraception Devices

by Distribution Channel

  • Hospitals Pharmacy
    • Public
    • Private 
  • Independent Pharmacy
  • Online Platform
  • Clinics
  • Others

by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • U.K.
    • Russia
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
      1.1. Market Definition and Scope
      1.2. Market Segmentation
      1.3. Key Research Objectives
      1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Contraceptive Market 

4. Market Overview
      4.1. Introduction
      4.2. Overview
      4.3. Key Market Indicators
      4.4. Market Dynamics
             4.4.1. Drivers
             4.4.2. Restraints
             4.4.3. Opportunity
      4.5. Global Contraceptive Market  Analysis and Forecasts, 2015–2025
             4.5.1. Market Revenue Projections (US$ Mn)
      4.6. Contraceptive Market  - Global Supply Demand Scenario
      4.7. Porter’s Five Force Analysis
      4.8. Value Chain Analysis
      4.9. Market Outlook

5. Global Contraceptive Market  Analysis and Forecasts, By Product
      5.1. Introduction & Definition
      5.2. Key Findings / Developments
      5.3. Key Trends
      5.4. Market Value Forecast By Product , 2015–2025
             5.4.1. Contraceptive Drugs
                      5.4.1.1. Oral Contraceptives
                                 5.4.1.1.1. Combined Contraceptives
                                 5.4.1.1.2. Mini-pills
                      5.4.1.2. Contraceptive Injectable
                      5.4.1.3. Topical Contraceptive Patch
             5.4.2. Contraceptive Devices
                      5.4.2.1. Male Contraceptive Devices
                      5.4.2.2. Female Contraceptive Devices
                                 5.4.2.2.1. Female Condoms
                                 5.4.2.2.2. Contraceptive Diaphragms
                                 5.4.2.2.3. Contraceptive Sponges
                                 5.4.2.2.4. Contraceptive Vaginal Rings
                                 5.4.2.2.5. Intrauterine Devices
                                 5.4.2.2.6. Sub-dermal Contraceptives Implants
                                 5.4.2.2.7. Non-Surgical Permanent Contraception Devices
      5.5. Market Attractiveness By Product

6. Global Contraceptive Market  Analysis and Forecasts, By Distribution Channel
      6.1. Introduction & Definition
      6.2. Key Findings / Developments
      6.3. Key Trends
      6.4. Market Value Forecast By Distribution Channel, 2015–2025
      6.4.1. Hospital Pharmacy
                      6.4.1.1. Public
                      6.4.1.2. Private
              6.4.2. Independent Pharmacy
              6.4.3. Online Platform
              6.4.4. Clinics
              6.4.5. Others
      6.5. Market Attractiveness By Distribution Channel

7. Global Contraceptive Market  Analysis and Forecasts, By Region
      7.1. Key Findings
      7.2. Policies and Regulations
      7.3. Market Value Forecast By Region
             7.3.1. North America 
             7.3.2. Europe 
             7.3.3. Asia Pacific 
             7.3.4. Latin America 
             7.3.5. Middle East and Africa 
      7.4. Market Attractiveness By Country/Region

8. North America Contraceptive Market  Analysis and Forecast
      8.1. Introduction
             8.1.1. Key Findings
             8.1.2. Policies and Regulations
             8.1.3. Key Trends
      8.2. Market Value Forecast By Product, 2015–2025
             8.2.1. Contraceptive Drugs
                      8.2.1.1. Oral Contraceptives
                                 8.2.1.1.1. Combined Contraceptives
                                 8.2.1.1.2. Mini-pills
                      8.2.1.2. Contraceptive Injectable
                      8.2.1.3. Topical Contraceptive Patch
             8.2.2. Contraceptive Devices
                      8.2.2.1. Male Contraceptive Devices
                      8.2.2.2. Female Contraceptive Devices
                                 8.2.2.2.1. Female Condoms
                                 8.2.2.2.2. Contraceptive Diaphragms
                                 8.2.2.2.3. Contraceptive Sponges
                                 8.2.2.2.4. Contraceptive Vaginal Rings
                                 8.2.2.2.5. Intrauterine Devices
                                 8.2.2.2.6. Sub-dermal Contraceptives Implants
                                 8.2.2.2.7. Non-Surgical Permanent Contraception Devices
      8.3. Market Value Forecast By Distribution Channel, 2015–2025
             8.3.1. Hospital Pharmacy
                      8.3.1.1. Public
                      8.3.1.2. Private
             8.3.2. Independent Pharmacy
             8.3.3. Online Platform
             8.3.4. Clinics
             8.3.5.Others
      8.4. Market Value Forecast By Country, 2015–2025
             8.4.1. U.S.
             8.4.2. Canada
      8.5. Market Attractiveness Analysis 
             8.5.1. By Product
             8.5.2. By Distribution Channel
             8.5.3. By Country 

9. Europe Contraceptive Market  Analysis and Forecast
      9.1. Introduction
             9.1.1. Key Findings
             9.1.2. Policies and Regulations
             9.1.3. Key Trends
      9.2. Market Value Forecast By Product, 2015–2025
             9.2.1. Contraceptive Drugs
                      9.2.1.1. Oral Contraceptives
                                 9.2.1.1.1. Combined Contraceptives
                                 9.2.1.1.2. Mini-pills
                      9.2.1.2. Contraceptive Injectable
                      9.2.1.3. Topical Contraceptive Patch
             9.2.2. Contraceptive Devices
                      9.2.2.1. Male Contraceptive Devices
                      9.2.2.2. Female Contraceptive Devices
                                 9.2.2.2.1. Female Condoms
                                 9.2.2.2.2. Contraceptive Diaphragms
                                 9.2.2.2.3. Contraceptive Sponges
                                 9.2.2.2.4. Contraceptive Vaginal Rings
                                 9.2.2.2.5. Intrauterine Devices
                                 9.2.2.2.6. Sub-dermal Contraceptives Implants
                                 9.2.2.2.7. Non-Surgical Permanent Contraception Devices
      9.3. Market Value Forecast By Distribution Channel, 2015–2025
             9.3.1. Hospital Pharmacy
                      9.3.1.1. Public
                      9.3.1.2. Private
             9.3.2. Independent Pharmacy
             9.3.3. Online Platform
             9.3.4. Clinics
             9.3.5. Others
      9.4. Market Value Forecast By Country, 2015–2025
             9.4.1. Germany
             9.4.2. France
             9.4.3. U.K.
             9.4.4. Spain
             9.4.5. Italy
             9.4.6. Russia
             9.4.7. Rest of Europe
      9.5. Market Attractiveness Analysis 
             9.5.1. By Product
             9.5.2. By Distribution Channel 
             9.5.4. By Country

10. Asia Pacific Contraceptive Market  Analysis and Forecast
      10.1. Introduction
             10.1.1. Key Findings
             10.1.2. Policies and Regulations
             10.1.3. Key Trends
      10.2. Market Value Forecast By Product, 2015–2025
             10.2.1. Contraceptive Drugs
                      10.2.1.1. Oral Contraceptives
                                 10.2.1.1.1. Combined Contraceptives
                                 10.2.1.1.2. Mini-pills
                      10.2.1.2. Contraceptive Injectable
                      10.2.1.3. Topical Contraceptive Patch
             10.2.2. Contraceptive Devices
                      10.2.2.1. Male Contraceptive Devices
                      10.2.2.2. Female Contraceptive Devices
                                 10.2.2.2.1. Female Condoms
                                 10.2.2.2.2. Contraceptive Diaphragms
                                 10.2.2.2.3. Contraceptive Sponges
                                 10.2.2.2.4. Contraceptive Vaginal Rings
                                 10.2.2.2.5. Intrauterine Devices
                                 10.2.2.2.6. Sub-dermal Contraceptives Implants
                                 10.2.2.2.7. Non-Surgical Permanent Contraception Devices
      10.3. Market Value Forecast By Distribution Channel, 2015–2025
             10.3.1. Hospital Pharmacy 
                      10.3.1.1 Public
                      10.3.1.2. Private
             10.3.2. Independent Pharmacy 
             10.3.3. Online Platforms 
             10.3.4. Clinics 
             10.3.5. Others
      10.4. Market Value Forecast By Country, 2015–2025
             10.4.1. China
             10.4.2. Japan
             10.4.3. India
             10.4.4. Australia & New Zealand
             10.4.5. Rest of Asia Pacific
      10.5. Market Attractiveness Analysis 
             10.5.1. By Product
             10.5.2. By Distribution Channel
             10.5.3. By Country

11. Latin America Contraceptive Market  Analysis and Forecast
      11.1. Introduction
             11.1.1. Key Findings
             11.1.2. Policies and Regulations
             11.1.3. Key Trends
      11.2. Market Value Forecast By Product , 2015–2025
             11.2.1. Contraceptive Drugs
                      11.2.1.1. Oral Contraceptives
                                 11.2.1.1.1. Combined Contraceptives
                                 11.2.1.1.2. Mini-pills
                      11.2.1.2. Contraceptive Injectable
                      11.2.1.3. Topical Contraceptive Patch
             11.2.2. Contraceptive Devices
                      11.2.2.1. Male Contraceptive Devices
                      11.2.2.2. Female Contraceptive Devices
                                 11.2.2.2.1. Female Condoms
                                 11.2.2.2.2. Contraceptive Diaphragms
                                 11.2.2.2.3. Contraceptive Sponges
                                 11.2.2.2.4. Contraceptive Vaginal Rings
                                 11.2.2.2.5. Intrauterine Devices
                                 11.2.2.2.6. Sub-dermal Contraceptives Implants
                                 11.2.2.2.7. Non-Surgical Permanent Contraception Devices
      11.3. Market Value Forecast By Distribution Channel, 2015–2025
             11.3.1. Hospital Pharmacy 
                      11.3.1.1. Public
                      11.3.1.2. Private
             11.3.2. Independent Pharmacy 
             11.3.3. Online Platforms 
             11.3.4. Clinics 
             11.3.5. Others
      11.4. Market Value Forecast By Country, 2015–2025
             11.4.1. Brazil
             11.4.2. Mexico
             11.4.3. Rest of Latin America
      11.5. Market Attractiveness Analysis 
             11.5.1. By Product
             11.5.2. By Distribution Channel
             11.5.4. By Country

12. Middle East and Africa Contraceptive Market  Analysis and Forecast
      12.1. Introduction
             12.1.1. Key Findings
             12.1.2. Policies and Regulations
             12.1.3. Key Trends
      12.2. Market Value Forecast By Product, 2015–2025
             12.2.1. Contraceptive Drugs
                      12.2.1.1. Oral Contraceptives
                                 12.2.1.1.1. Combined Contraceptives
                                 12.2.1.1.2. Mini-pills
                      12.2.1.2. Contraceptive Injectable
                      12.2.1.3. Topical Contraceptive Patch
             12.2.2. Contraceptive Devices
                      12.2.2.1. Male Contraceptive Devices
                      12.2.2.2. Female Contraceptive Devices
                                 12.2.2.2.1. Female Condoms
                                 12.2.2.2.2. Contraceptive Diaphragms
                                 12.2.2.2.3. Contraceptive Sponges
                                 12.2.2.2.4. Contraceptive Vaginal Rings
                                 12.2.2.2.5. Intrauterine Devices
                                 12.2.2.2.6. Sub-dermal Contraceptives Implants
                                 12.2.2.2.7. Non-Surgical Permanent Contraception Devices
      12.3. Market Value Forecast By End User , 2015–2025
             12.3.1. Hospital Pharmacy 
                      12.3.1.1. Public
                      12.3.1.2. Private
             12.3.2. Independent Pharmacy
             12.3.3. Online Platform
             12.3.4. Clinics
             12.3.5. Others
      12.4. Market Value Forecast By Country , 2015–2025
             12.4.1. GCC Countries
             12.4.2. South Africa
             12.4.3. Rest of Middle East and Africa
      12.5. Market Attractiveness Analysis 
             12.5.1. By Product
             12.5.2. By Distribution Channel 
             12.5.3. By Country

13. Competition Landscape
      13.1. Market Player – Competition Matrix (By Tier and Size of companies)
      13.2. Market Share Analysis By Company (2016)
      13.3. Company Profiles 
             13.3.1. Merck & Co., Inc.
                      13.4.1.1. Overview
                      13.4.1.2. Financials
                      13.4.1.3. Recent Developments
                      13.4.1.4. Strategy
             13.3.2. Cipla Inc.
                      13.4.2.1. Overview
                      13.4.2.2. Financials
                      13.4.2.3. Recent Developments
                      13.4.2.4. Strategy
             13.3.3. Allergan plc
                      13.4.3.1. Overview
                      13.4.3.2. Financials
                      13.4.3.3. Recent Developments
                      13.4.3.4. Strategy
             13.3.4. Bayer AG
                      13.4.4.1. Overview
                      13.4.4.2. Financials
                      13.4.4.3. Recent Developments
                      13.4.4.4. Strategy
             13.3.5. HLL Lifecare Limited
                      13.4.5.1. Overview
                      13.4.5.2. Financials
                      13.4.5.3. Recent Developments
                      13.4.5.4. Strategy
             13.3.6. Mankind Pharma
                      13.4.6.1. Overview
                      13.4.6.2. Financials
                      13.4.6.3. Recent Developments
                      13.4.6.4. Strategy
             13.3.7. Pfizer, Inc.
                      13.4.7.1. Overview
                      13.4.7.2. Financials
                      13.4.7.3. Recent Developments
                      13.4.7.4. Strategy
             13.3.8. Teva Pharmaceutical Industries Ltd
                      13.4.8.1. Overview
                      13.4.8.2. Financials
                      13.4.8.3. Recent Developments
                      13.4.8.4. Strategy
             13.3.9. Mithra Pharmaceuticals
                      13.4.9.1. Overview
                      13.4.9.2. Financials
                      13.4.9.3. Recent Developments
                      13.4.9.4. Strategy
             13.3.10. Janssen Pharmaceutical Company
                      13.4.10.1. Overview
                      13.4.10.2. Financials
                      13.4.10.3. Recent Developments
                      13.4.10.4. Strategy
             13.3.11. Reckitt Benckiser Group plc
                      13.4.11.1. Overview
                      13.4.11.2. Financials
                      13.4.11.3. Recent Developments
                      13.4.11.4. Strategy

List of Tables

Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025
Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2015–2025
Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2015–2025
Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2015–2025
Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2015–2025
Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2015–2025

List of Figures

Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Global Contraceptives Market Value Share, by Product (2016)
Figure 03: Global Contraceptives Market Value Share, by Distribution Channel (2016)
Figure 04: Global Contraceptives Market Value Share, by Region (2016)
Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 06: Global Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2025
Figure 08: Global Contraceptives Market Attractiveness, by Contraceptive Drugs, 2017–2025
Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2025
Figure 10: Global Contraceptives Market Attractiveness, by Oral Contraceptives, 2017–2025
Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2025
Figure 12: Global Contraceptives Market Attractiveness, by Contraceptive Devices, 2017–2025
Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2025
Figure 14: Global Contraceptives Market Attractiveness, by Female Contraceptive Devices, 2017–2025
Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive  Drugs, 2015–2025
Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2015–2025
Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 18: Global Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2015–2025
Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2015–2025
Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2015–2025
Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2015–2025
Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2025 
Figure 25: Global Contraceptives Market Attractiveness, by Region, 2017–2025
Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 27: North America Contraceptives Market Attractiveness, by Country 2017–2025
Figure 28: North America Contraceptive Market Value Share, by Country, 2017 and 2025
Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 30: North America Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 32: North America Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015–2025
Figure 34: Europe Contraceptives Market Attractiveness, by Country, 2017–2025
Figure 35: Europe Contraceptive Market Value Share, by Country, 2017 and 2025
Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2025
Figure 37: Europe Contraceptives Market Attractiveness, by Product, 2017–2025
Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 39: Europe Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 41: Asia Pacific Contraceptives Market Attractiveness, by Country 2017–2025
Figure 42: Asia Pacific Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 44: Asia Pacific Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 46: Asia Pacific Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 48: Latin America Contraceptives Market Attractiveness, by Country 2017–2025
Figure 49: Latin America Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 51: Latin America Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 53: Latin America Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 55: Middle East & Africa Contraceptives Market Attractiveness, by Country 2017–2025
Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country, 2017 and 2025
Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2025
Figure 58: Middle East & Africa Contraceptives Market Attractiveness, by Product Type, 2017–2025
Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2025
Figure 60: Middle East & Africa Contraceptives Market Attractiveness, by Distribution Channel, 2017–2025
Figure 61: Global Contraceptives Drugs Market Share, by Company, 2016 
Figure 62: Global Contraceptives Devices Market Share, by Company, 2016

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Contraceptives Market